Full Name
Wan-Teck Darren Lim
Variants
Lim, W.-T.
 
Main Affiliation
 
 
Email
gmslwtd@nus.edu.sg
 

Publications

Results 1-20 of 47 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)
12018A merged lung cancer transcriptome dataset for clinical predictive modelingLim, S.B; Tan, S.J; Lim, W.-T ; Lim, C.T 
2Sep-2012A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancerBible, K.C.; Suman, V.J.; Menefee, M.E.; Smallridge, R.C.; Molina, J.R.; Maples, W.J.; Karlin, N.J.; Traynor, A.M.; Kumar, P.; Goh, B.C.; Lim, W.-T. ; Bossou, A.R.; Isham, C.R.; Webster, K.P.; Kukla, A.K.; Bieber, C.; Burton, J.K.; Harris, P.; Erlichman, C.
3Nov-2023A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaRazak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein Jr, George; Solomon, Benjamin; Lim, Darren Wan-Teck ; Hong, Ruey-Long; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre
415-Aug-2011A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinomaLim, W.-T. ; Ng, Q.-S.; Ivy, P.; Leong, S.-S.; Singh, O.; Chowbay, B.; Gao, F.; Thng, C.H.; Goh, B.-C. ; Tan, D.S.-W.; Koh, T.S.; Toh, C.-K.; Tan, E.-H. 
5Dec-2022A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCLai, Gillianne GY ; Yeo, Jia Chi; Jain, Amit ; Zhou, Siqin ; Pang, Mengyuan; Alvarez, Jacob JS; Sim, Ngak Leng; Tan, Aaron C ; Suteja, Lisda; Lim, Tze Wei; Guo, Yu Amanda; Shen, Meixin; Saw, Stephanie PL ; Rohatgi, Neha; Yeong, Joe PS; Takano, Angela ; Lim, Kiat Hon ; Gogna, Apoorva ; Too, Chow Wei ; Da Zhuang, Kun ; Tan, Wan Ling ; Kanesvaran, Ravindran ; Ng, Quan Sing ; Ang, Mei Kim ; Rajasekaran, Tanujaa ; Wang, Lanying; Toh, Chee Keong ; Lim, Wan-Teck ; Tam, Wai Leong ; Tan, Sze Huey ; Skanderup, Anders MJ ; Tan, Eng-Huat ; Tan, Daniel SW 
62017A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSoh, S.X; Siddiqui, F.J ; Allen, J.C ; Kim, G.W; Lee, J.C; Yatabe, Y; Soda, M; Mano, H; Soo, R.A ; Chin, T.-M ; Ebi, H; Yano, S; Matsuo, K; Niu, X; Lu, S; Isobe, K; Lee, J.-H; Yang, J.C; Zhao, M; Zhou, C; Lee, J.-K; Lee, S.-H; Lee, J.Y; Ahn, M.-J; Tan, T.J; Tan, D.S ; Tan, E.-H; Ong, S.T ; Lim, W.-T 
73-Sep-2019Addressing cellular heterogeneity in tumor and circulation for refined prognosticationLim, Su Bin; Yeo, Trifanny ; Lee, Wen Di ; Bhagat, Ali Asgar S ; Tan, Swee Jin; Tan, Daniel Shao Weng ; Lim, Wan-Teck ; Lim, Chwee Teck 
82017An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancerLim, S.B; Tan, S.J; Lim, W.-T ; Lim, C.T 
91-Sep-2020An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid CancerBible, Keith C; Menefee, Michael E; Lin, Chia-Chi Josh; Millward, Michael J; Maples, William J; Goh, Boon Cher ; Karlin, Nina J; Kane, Madeleine A; Adkins, Douglas R; Molina, Julian R; Donehower, Ross C; Lim, Wan-Teck ; Flynn, Patrick J; Richardson, Ronald L; Traynor, Anne M; Rubin, Joseph; LoRusso, Patricia M; Smallridge, Robert C; Burton, Jill K; Suman, Vera J; Kumar, Aditi; Voss, Jessie S; Rumilla, Kandalaria M; Kipp, Benjamin R; Chintakuntlawar, Ashish; Harris, Pamela; Erlichman, Charles
1027-Sep-2021Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signaturesTeng, Yvonne HF ; Quah, Hong Sheng ; Suteja, Lisda; Dias, Joao ML; Mupo, Annalisa; Bashford-Rogers, Rachael JM; Vassiliou, George S; Chua, Melvin LK; Tan, Daniel SW ; Lim, Darren WT ; Iyer, N Gopalakrishna 
1110-May-2018Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)Ma, Brigette BY; Lim, Wan-Teck ; Goh, Boon-Cher ; Hui, Edwin P; Lo, Kwok-Wai; Pettinger, Adam; Foster, Nathan R; Riess, Jonathan W; Agulnik, Mark; Chang, Alex YC; Chopra, Akhil; Kish, Julie A; Chung, Christine H; Adkins, Douglas R; Cullen, Kevin J; Gitlitz, Barbara J; Lim, Dean W; To, Ka-Fai; Chan, KC Allen; Lo, YM Dennis; King, Ann D; Erlichman, Charles; Yin, Jun; Costello, Brian A; Chan, Anthony TC
122019Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).Fong, Pei Yuan; Tan, Sze Huey ; Lim, Darren Wan Teck ; Tan, Eng Huat ; Ng, Quan Sing ; Sommat, Kiattisa ; Tan, Daniel Shao Weng ; Ang, Mei Kim 
132014Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancerTan, D.S.W; Haaland, B ; Gan, J.M; Tham, S.C; Sinha, I; Tan, E.H; Lim, K.H ; Takano, A ; Krisna, S.S; Thu, M.M.M; Liew, H.P; Ullrich, A; Lim, W.-T ; Chua, B.T
1415-May-2023Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinomaLim, Darren Wan-Teck ; Kao, Hsiang-Fong; Suteja, Lisda; Li, Constance H ; Quah, Hong Sheng ; Tan, Daniel Shao-Weng ; Tan, Sze-Huey ; Tan, Eng-Huat ; Tan, Wan-Ling ; Lee, Justina Nadia; Wee, Felicia Yu-Ting; Jain, Amit; Goh, Boon-Cher ; Chua, Melvin LK ; Liao, Bin-Chi; Ng, Quan Sing ; Hong, Ruey-Long; Ang, Mei-Kim ; Yeong, Joe Poh-Sheng; Iyer, N Gopalakrishna 
158-Oct-2019Compendiums of cancer transcriptomes for machine learning applicationsLim, Su Bin; Tan, Swee Jin; Lim, Wan-Teck ; Lim, Chwee Teck 
16May-2021Complete disease remission in a <i>TP53</i> and <i>KRAS</i> co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case reportZhu, Shuai; Zhao, Shikang; Zhang, Qian; Li, Shuo; Ren, Dian; Ren, Fan; Zu, Lingling; Wang, Yanye; Lei, Xi; Zhou, Ning; Shi, Tao; Xu, Dongbo; Chen, Gang; Lim, Wan-Teck ; Giusti, Raffaele; Wu, Abraham J; Xu, Song
17Sep-2022Comprehensive analysis of T cell receptor repertoire in patients with<i> KRAS</i> mutant non-small cell lung cancerWang, Yadong; Peng, Ling; Zhao, Ming; Xiong, Yuanyuan; Xue, Jianchao; Li, Bowen; Huang, Zhicheng; Liu, Xinyu ; Yang, Xiaoying; Song, Yang; Bing, Zhongxing; Guo, Chao; Tian, Zhenhuan; Gao, Chao; Cao, Lei ; Cao, Zhili; Li, Ji; Jiang, Xu; Si, Xiaoyan; Zhang, Li; Li, Xiaoguang; Zheng, Zhibo; Song, Mengmeng; Chen, Rongrong; Lim, Wan-Teck ; Pavan, Alberto; Romero, Atocha; Liang, Naixin; Yang, Huaxia; Li, Shanqing
1826-Apr-2016Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerTan, Chye Ling ; Lim, Tse Hui ; Lim, Tony KH; Tan, Daniel Shao-Weng ; Chua, Yong Wei; Ang, Mei Kim ; Pang, Brendan ; Lim, Chwee Teck ; Takano, Angela ; Lim, Alvin Soon-Tiong ; Leong, Man Chun; Lim, Wan-Teck 
192018Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspectiveTan, P.-T; Aziz, M.I.A; Pearce, F; Lim, W.-T ; Wu, D.B.-C; Ng, K
2025-Sep-2019Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platformYap, Yoon-Sim ; Leong, Man Chun; Chua, Yong Wei; Loh, Kiley Wei Jen ; Lee, Guek Eng; Lim, Elaine Hsuen ; Dent, Rebecca ; Ng, Raymond Chee Hui ; Lim, John Heng-Chi ; Singh, Garima; Tan, Angela ; Guan, Guofeng; Wu, Andrew; Lee, Yi Fang; Bhagat, Ali Asgar S ; Lim, Darren Wan-Teck